Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

TGAC Director to step down

4 October 2012

The Genome Analysis Centre's (TGAC's) Board of Trustees and BBSRC have announced that Prof Jane Rogers has decided to step down as Director at the end of the year.

Prof Rogers has been director for the past five years and successfully launched TGAC, on the Norwich Research Park, in 2009 with funding from BBSRC and co-investment from Norwich local authorities and a regional development agency.

Chair of TGAC's Trustee Board, Professor Richard Cogdell, said: "I am sorry to see Jane leave and wish to thank her for all of her hard work and dedication in turning an idea to a functioning institute."

BBSRC Chief Executive, Prof Douglas Kell, said: "Everyone involved in TGAC and in the wider bioscience community owes a huge debt to Jane for her work in establishing and developing TGAC into a recognised international centre. Since her appointment she has worked to build the institute from scratch, to recruit a talented team around her and to steer TGAC through its first institute assessment exercise. One of Jane's most important achievements has been to forge close relationships with partners, ensuring that the institute has been at the forefront of advances in next generation sequencing. Everyone at BBSRC, none more so than me, wish her the best of luck for the future."

Prof Jane Rogers said "I am extremely proud of what I have achieved at TGAC and know that the team I have helped bring together possess the right skills and expertise to contribute internationally in genomics and computational bioscience."

Dr Mario Caccamo, currently Head of Bioinformatics has been appointed Deputy Director and will temporarily lead the institute while recruitment of a new Director begins.


About TGAC

The Genome Analysis Centre is a vibrant, contemporary research institute and registered charity (Charity No. 1136213 (ref 1)) working in an area of rapid technological development and innovation.

TGAC is strategically funded by The Biotechnology and Biological Sciences Research Council (BBSRC) to lead the development of a skill base in bioinformatics and a genomics technology platform for UK bioscience. TGAC was set up in 2009 with capital and revenue funding from BBSRC in collaboration with Norfolk County Council, Norwich City Council, South Norfolk Council and the Greater Norwich Development Partnership and are TGAC's Patrons. TGAC has now secured funding from BBSRC for the next 3 years of over £19 Million with indicated level going into 2017.

The Institute is located on the Norwich Research Park, together with its partners: the John Innes Centre, the Institute of Food Research, The Sainsbury Laboratory, the University of East Anglia and the Norfolk and Norwich University Hospital. The research park has an excellent reputation for research in plant and microbial sciences, interdisciplinary environmental science and food, diet and health, to which TGAC contributes strengths in genomics and bioinformatics.

TGAC is a UK hub for innovative Bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. This has been boosted recently by an e-Infrastructure grant to expand the data storage capacity to a multi-petabyte unit, deploying a high performance cluster and large-memory server enabling the allocation of processes requiring several terabytes of computing memory.

TGAC's state of the art DNA sequencing facility operates multiple complementary technologies for data generation that provide the foundation for analyses furthering our fundamental understanding of genomes and how they function. We aim to be at the forefront of technological advances and are developing and implementing technologies to generate and analyse new types of data. We also develop novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational bioscience.

TGAC has one fully owned subsidiary, Genome Enterprise Ltd (GEL) via which it offers genomic and bioinformatics services on a trading basis and works with commercial providers on a partnership basis. TGAC also receives specific funding to enable knowledge exchange programmes which are supported across the institute teams.

For more information about TGAC see



Tags: press release